All Stories

  1. Emerging concept of genomic islands in bacterial adaptation and pathogenicity
  2. Advancements in CRISPR–Cas Systems for Genome Editing towards Eradication of Human Microbial Pathogens
  3. Recent development in CRISPR-Cas systems for cardiac disease
  4. Insights of Neuroreceptor Endocytosis and Signaling in Health and Disease
  5. Opioid Receptor Endocytosis and Signaling
  6. Artificial intelligence for cell-free systems
  7. Computational biology for cell-free systems
  8. Mechanism of Circular Bioeconomy
  9. Progress in Conversion of Biomass into Biofuels
  10. Microwave-Assisted Enzymatic Green Solvent Technology for the Extraction and Characterization of Sesame Seed Oil
  11. Challenges and Opportunities of Gene Therapy in Cancer
  12. Role of Bioinformatics in Non-coding RNA Analysis
  13. In Silico Optimization of DNA Codons in Genes Encoded by Various Variants of Ebola Virus
  14. Multi-Omics Analysis of the Human Microbiome
  15. Drug repurposing for fungal infections
  16. Drug repurposing for personalized medicine
  17. Exploring the potential of drug repurposing for treating depression
  18. Metagenomics Insight into the Mycobiome Analysis
  19. Metagenomics in the Census of Microbial Diversity
  20. Metatranscriptomics, Metaproteomics, and Metabolomics Approaches for Microbiome Characterization
  21. Multi-omics in Gut Microbiome
  22. Overview on Multi-omics Research in Microbiome Analysis
  23. Advances in CRISPR-Cas systems for gut microbiome
  24. Advances in CRISPR-Cas systems for human bacterial disease
  25. Chloroplast Genomics and Their Uses in Crop Improvement
  26. Emerging Tools for Generating Genomics Data
  27. Microplastics in Human Health
  28. In silico codon optimization of the variant antigen-encoding genes of diverse strains of Zika Virus
  29. In silico optimization of DNA codons in genes encoded by various strains of Ebola Virus
  30. Nanotechnology and nucleic acid nanoparticles for treatment of metabolic disorders
  31. Exploring the potential of microfluidics for next-generation drug delivery systems
  32. MiR-128 and MiR-195 Modulate Ligand-Dependent Downregulation of Guanylyl Cyclase/Atrial Natriuretic Peptide Receptor-A
  33. MicroRNA-128 regulates ligand-dependent downregulation of guanylyl cyclase/atrial natriuretic peptide receptor-A
  34. Evaluation of Vaccine Hesitancy and the Influence of Side Effects on Vaccination Drive amidst Covid-19 Pandemic in India
  35. Microbial Genomic Islands in Adaptation and Pathogenicity
  36. Cutting-Edge Tools to Assess Microbial Diversity and Their Function in Land Remediation
  37. An Introduction to Microbial Genomic Islands for Evolutionary Adaptation and Pathogenicity
  38. Applications of bioinformatics in epigenetics
  39. Epigenetics in renal diseases
  40. Genetic Manipulation of Crop for Enhanced Food Quality and Nutrition Toward Sustainable Production
  41. Genomic Islands in Marine Bacteria
  42. Insight into epigenetics and human diseases
  43. Phage and phage cocktails formulations
  44. Phage for treatment of Vibrio cholerae infection
  45. State-of-the-art techniques to study epigenetics
  46. Yeast Cell Factory for Production of Biomolecules
  47. Receptor biology: Challenges and opportunities
  48. Endocytosis and signaling of angiotensin II type 1 receptor
  49. An overview of receptor endocytosis and signaling
  50. Amyloid precursor protein in Alzheimer's disease
  51. Emerging tools for studying receptor endocytosis and signaling
  52. Endocytosis and signaling of 5-HT1A receptor
  53. Glutamate receptor endocytosis and signaling in neurological conditions
  54. Copyright
  55. Copyright
  56. Contributors
  57. Contributors
  58. Index
  59. Index
  60. Copyright
  61. Copyright
  62. Contributors
  63. Contributors
  64. Index
  65. Index
  66. Preface
  67. Preface
  68. Preface
  69. Preface
  70. Ligand-Dependent Downregulation of Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Role of miR-128 and miR-195
  71. Microbial Production and Emerging Applications of Lantibiotics
  72. Phage engineering and phage‐assisted CRISPR‐Cas delivery to combat multidrug‐resistant pathogens
  73. Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications
  74. DNA/RNA-based self-assemblies for bio-sensing
  75. Dysbiosis of human microbiome and infectious diseases
  76. Beneficial Effects of Psychobiotic Bacteria, Cyanobacteria, Algae, and Modified Yeast in Various Food Industries
  77. Recent development in DNA synthesis technology
  78. Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-Targeting Intracellular Checkpoint CISH
  79. Species Identification of Non-tuberculous Mycobacteria (NTM) from Sputum Samples of TB Suspects in a Tertiary Care Centre from North India
  80. Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-targeting Intracellular Checkpoint CISH
  81. In silico DNA codon optimization of the variant antigen-encoding genes of diverse strains of Nipah virus
  82. Role of Bioinformatics in MicroRNA Analysis
  83. CRISPR-Cas systems for genome editing of mammalian cells
  84. CRISPR-Cas9 for treating hereditary diseases
  85. Genome editing in cardiovascular diseases
  86. Bioinformatics Tools and Software
  87. Role of Bioinformatics in Biological Sciences
  88. Microbial Production of Vitamins
  89. Biofilm in bioremediation
  90. Metagenomics approach for bioremediation: challenges and perspectives
  91. Current Status and Challenges of DNA Sequencing
  92. CRISPR technology for genome editing
  93. Abstract P2045: Genetic Disruption of Npr1 Depletes T Regulatory Cells and Provokes High Levels of Proinflammatory Cytokines and Fibrosis in the Kidneys of Female Mutant Mice
  94. Emerging concepts of receptor endocytosis and concurrent intracellular signaling: Mechanisms of guanylyl cyclase/natriuretic peptide receptor-A activation and trafficking
  95. Genetic disruption ofNpr1depletes regulatory T cells and provokes high levels of proinflammatory cytokines and fibrosis in the kidneys of female mutant mice
  96. A Study of Non-Tuberculous Mycobacterial (NTM) Disease Among Tuberculosis Suspects at a Tertiary Care Center in North India
  97. A prospective study of non-tuberculous mycobacterial disease among tuberculosis suspects at a tertiary care centre in north India
  98. Abstract P161: Effect of Rapamycin on the Expression of T Regulatory Cells, Foxp3, and Toll-Like Receptors in the Kidneys of Npr1 Gene-Knockout Mice
  99. Microbial biofilm: current challenges in health care industry
  100. Current Developments and Potential Applications of Biosensor Technology
  101. MicroRNA in Prognosis, Diagnosis and Therapy of Cancer
  102. Epigenetic Remodeling of Delta FosB Protein: Its Role in Regulation of Stress
  103. Clathrin-dependent internalization, signaling, and metabolic processing of guanylyl cyclase/natriuretic peptide receptor-A
  104. A Potential Screening of Peptide Deformylase Inhibitors Towards the Control of Aeromonas hydrophila
  105. Toll-Like Receptor 11: Role in Post-Transplantation Renal Infections
  106. CRISPR/Cas-9 System: Magnificent Tool for Genome Editing
  107. Recent advances and challenges of the use of cyanobacteria towards the production of biofuels
  108. Retinoic acid and sodium butyrate suppress the cardiac expression of hypertrophic markers and proinflammatory mediators in Npr1 gene-disrupted haplotype mice
  109. Role of FQQI motif in the internalization, trafficking, and signaling of guanylyl-cyclase/natriuretic peptide receptor-A in cultured murine mesangial cells
  110. Subcellular trafficking of guanylyl cyclase/natriuretic peptide receptor-A with concurrent generation of intracellular cGMP
  111. FQQI motif in the C‐terminus of Guanylyl‐cyclase/Natriuretic Peptide Receptor‐A mediates intracellular trafficking in mouse mesangial cells
  112. INCREASED RENAL EXPRESSION OF TOLL‐LIKE RECEPTOR‐4 IN GUANYLYL CYCLASE/NATRIURETIC PEPTIDE RECEPTOR‐A GENE‐DISRUPTED FEMALE MICE
  113. Advancement of Emerging Tools in Synthetic Biology for the Designing and Characterization of Genetic Circuits
  114. Metabolic Engineering of Microorganisms for Biosynthesis of Antibiotics
  115. Homologues of insecticidal toxin complex genes within a genomic island in the marine bacteriumVibrio parahaemolyticus
  116. All-Trans Retinoic Acid and Sodium Butyrate Enhance Natriuretic Peptide Receptor A Gene Transcription: Role of Histone Modification
  117. A novel cytoplasmic tail fqqi motif mediates internalization and intracellular trafficking of guanylyl‐cyclase/natriuretic peptide receptor‐A (539.4)
  118. Metabolic Engineering of Biosynthetic Pathway for Production of Renewable Biofuels
  119. Molecular characterization of major and minor rDNA repeats and genetic variability assessment in different species of mahseer found in North India
  120. Abstract 282: Aromatic Residue-based Tetrapeptide Fqqi Motif Mediates Internalization and Trafficking of Guanylyl-cyclase/natriuretic Peptide Receptor-a in Mouse Mesangial Cells
  121. Development of diagnostic and vaccine markers through cloning, expression, and regulation of putative virulence-protein-encoding genes of Aeromonas hydrophila
  122. Quantitative internalization kinetics of the green fluorescence protein‐tagged guanylyl (guanylate) cyclase/natriuretic peptide receptor‐A in Human Embryonic Kidney‐293 cells
  123. ATP4A gene regulatory network for fine-tuning of proton pump and ion channels
  124. Analysis of the multicopper oxidase gene regulatory network of Aeromonas hydrophila
  125. Gene network analysis of Aeromonas hydrophila for novel drug target discovery
  126. Molecular Assessment of 16S-23S rDNA Internal Transcribed Spacer Length Polymorphism of <i>Aeromonas hydrophila</i>
  127. Gene Cloning and Homology Modeling of the 3-Oxoacyl-ACP Synthase from Aeromonas hydrophila for Drug Discovery
  128. Molecular detection and cloning of thermostable hemolysin gene from Aeromonas hydrophila
  129. The β-Ketoacyl-ACP Synthase from Mycobacterium tuberculosis as Potential Drug Targets
  130. Codon optimization of the major antigen encoding genes of diverse strains of influenza a virus
  131. Role of Metabolites and Significance of SH Groups in the Action of NADP+-Linked Isocitrate Dehydrogenase of Urdbean Seeds (Phaseolus mungo L.)
  132. Cytogenetic characterization of an endemic mahseer, Tor mosal mahanadicus (David, 1953; Teleostei : Cyprinidae)
  133. Nucleotide variation and physical mapping of ribosomal genes using FISH in genus Tor (Pisces, Cyprinidae)
  134. Nucleotide Sequences and Chromosomal Localization of 45S and 5S rDNA inNeolissochilus hexagonolepis(Pisces, Cyprinidae), Using Dual-Color Fish
  135. Genotyping of Aeromonas hydrophila by Box elements
  136. Population distribution of 45S and 5S rDNA in golden mahseer, Tor putitora: population-specific FISH marker
  137. Karyotypic diversity and evolution of seven mahseer species (Cyprinidae) from India
  138. Extensive NOR site polymorphism in geographically isolated populations of Golden mahseer,Tor putitora
  139. Bacterial resistance to oxytetracycline in different life stages of Indian freshwater carp aquaculture system
  140. Chromosomal localization of 18S and 5S rDNA using FISH in the genus Tor (Pisces, Cyprinidae)
  141. HLA Class I and II Binding Promiscuity of the T-cell Epitopes in Putative Proteins of Hepatitis B virus